NCT07215676View on ClinicalTrials.gov

A Trial of a Multi-Component Nutritional Supplement in Hydrogen-Dominant Small Intestinal Bacterial Overgrowth

NANot yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Small Intestinal Bacterial Overgrowth Syndrome (SIBO)Small Intestinal Bacterial Overgrowth
Interventions
DIETARY_SUPPLEMENT

AV1PD1A

Saccharomyces cerevisiae fermentate, N-acetyl-glucosamine, Saccharomyces boulardii, heat-killed Lactobacillus rhamnosus, methylcobalamin, berberine, ginger extract

Trial Locations (1)

97201

NUNM - Helfgott Research Institute, Portland

All Listed Sponsors
lead

National University of Natural Medicine

OTHER

NCT07215676 - A Trial of a Multi-Component Nutritional Supplement in Hydrogen-Dominant Small Intestinal Bacterial Overgrowth | Biotech Hunter | Biotech Hunter